Cooperative Agreement U01CK000539

This $199,775 Project Grant from the National Science Foundation Division of Environmental Biology will support research at the University of California, Los Angeles to develop models to understand and predict the spread of monkeypox virus. The research will analyze monkeypox virus surveillance data and transmission patterns in both core and non-core populations. Mathematical models will be built to design disease control strategies, such as comparing outcomes from reducing transmission in...

This Project Grant from the National Science Foundation's Social, Behavioral, and Economic Sciences program provides $198,092 to fund a survey-based research project examining risk perceptions and behavioral intentions related to the 2022 monkeypox outbreak. The award was made to The Research Foundation for the State University of New York on November 1, 2022, with a completion date of October 31, 2023. Specifically, the funding will support a large-scale survey of 1,000 individuals to...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $547,988 Project Grant to the University of Pittsburgh under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 11, 2025. The funding supports the development and testing of a novel monkeypox vaccine based on a replication-inducible version of the ACAM2000 smallpox vaccine. The proposed vaccine aims to retain the immunogenicity of ACAM2000 while reducing adverse side effects, particularly for...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $431,750 Project Grant to Arizona State University (ASU) to develop a safer and more effective vaccine for monkeypox/smallpox. The funding, provided through the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), will support the establishment of a monkeypox skin cast/EIJ mouse model to evaluate the virulence of multiple monkeypox virus strains and assess the efficacy of a novel, highly...

The Kansas Department of Health and Environment (KDHE) has been awarded a $2,679,110 Cooperative Agreement under the Public Health Emergency Response: Cooperative Agreement for Emergency Response: Public Health Crisis Response (CFDA 93.354) program by the Centers for Disease Control and Prevention (CDC). The award, effective January 17, 2025 through January 16, 2026, will support KDHE's efforts to respond to the monkeypox (MPOX) public health crisis in Kansas. Key objectives include: Focusing on...

This $221,105 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) is supporting research to investigate how poxviruses, such as monkeypox, can rapidly diversify their genomes to overcome host immune defenses. The research aims to advance understanding of the mechanisms by which host APOBEC enzymes can both restrict and promote viral evolution, with the goal of informing strategies to...

This $100,000 Project Grant awarded on June 3, 2024 by the U.S. Department of State Bureau of African Affairs under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) Program (CFDA 19.029) will support community-led monitoring to improve healthcare services in Kinshasa, Democratic Republic of the Congo. The prime awardee, Miscellaneous Foreign Awardees (doing business as Federal Egov IAE Initiative - Generic Entity Identifier), will utilize the funding over the 12-month period ending...

This $2,777,976 Cooperative Agreement, awarded by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program, aims to improve the response to HIV and ensure sustained epidemic control in targeted areas of the Democratic Republic of Congo (DRC). The primary awardee, Family Health International (FHI 360), will implement activities to decrease new HIV infections and reduce HIV-associated morbidity and mortality in the...

This Cooperative Agreement, awarded by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283), provides $265,000.00 in funding to the Direction Of Disease Control, Epidemics And Pandemics in Cameroon. The purpose of this 5-year award, with a start date of September 30, 2025 and a completion date of September 29, 2030, is to protect and improve public health globally by building and strengthening public health impact system...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $147,290 Project Grant under the Allergy and Infectious Diseases Research (CFDA 93.855) program to the University of Sciences, Techniques and Technologies of Bamako (Usttb) in Mali. The grant, titled "Understanding the Persistence of Dengue Epidemic and Associated Risk Factors in Urban Bamako Mali", aims to assess the burden and risk factors associated with dengue fever disease (DFD) in Mali. The key objectives...